Life Molecular Imaging Overview
- Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
79
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
Life Molecular Imaging General Information
Description
Developer of novel PET tracers designed for molecular imaging research and development services. The company through its PET tracers helps improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes as well as provide services such as research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities, thereby allowing physicians, pharma industry and academia greater access to established and innovative imaging agents for clinical trials and clinical routine.
Contact Information
Website
www.life-mi.com
Formerly Known As
Piramal Imaging
Ownership Status
Acquired/Merged
(Operating Subsidiary)
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Diagnostic Equipment
Parent Company
Primary Office
- Tegeler Strasse 6-7
- 13353 Berlin
- Germany
+49 030 000000000
Life Molecular Imaging Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Life Molecular Imaging Patents
Life Molecular Imaging Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3088219-A1 | Novel method of preparing an imaging compound | Pending | 24-Jan-2018 | 0000000000 | |
| US-20210038747-A1 | Novel method of preparing an imaging compound | Pending | 24-Jan-2018 | 0000000000 | |
| EP-3743427-A1 | Novel method of preparing an imaging compound | Pending | 24-Jan-2018 | 0000000000 | |
| EP-3743423-A1 | Gamma-carboline compounds for the detection of tau aggregates | Pending | 24-Jan-2018 | 0000000000 | |
| EP-3743426-A1 | Azacarboline compounds for the detection of tau aggregates | Pending | 24-Jan-2018 | G01N33/60 |
Life Molecular Imaging Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Ludger Dinkelborg Ph.D | Managing Director | ||
| Michel Jongens | Managing Director | ||
| Andrew Stephens MD | Chief Medical Officer |
Life Molecular Imaging Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Life Molecular Imaging Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|